» Articles » PMID: 38691440

Antibiotic Dose and Nutrient Availability Differentially Drive the Evolution of Antibiotic Resistance and Persistence

Overview
Journal ISME J
Date 2024 May 1
PMID 38691440
Authors
Affiliations
Soon will be listed here.
Abstract

Effective treatment of bacterial infections proves increasingly challenging due to the emergence of bacterial variants that endure antibiotic exposure. Antibiotic resistance and persistence have been identified as two major bacterial survival mechanisms, and several studies have shown a rapid and strong selection of resistance or persistence mutants under repeated drug treatment. Yet, little is known about the impact of the environmental conditions on resistance and persistence evolution and the potential interplay between both phenotypes. Based on the distinct growth and survival characteristics of resistance and persistence mutants, we hypothesized that the antibiotic dose and availability of nutrients during treatment might play a key role in the evolutionary adaptation to antibiotic stress. To test this hypothesis, we combined high-throughput experimental evolution with a mathematical model of bacterial evolution under intermittent antibiotic exposure. We show that high nutrient levels during antibiotic treatment promote selection of high-level resistance, but that resistance mainly emerges independently of persistence when the antibiotic concentration is sufficiently low. At higher doses, resistance evolution is facilitated by the preceding or concurrent selection of persistence mutants, which ensures survival of populations in harsh conditions. Collectively, our experimental data and mathematical model elucidate the evolutionary routes toward increased bacterial survival under different antibiotic treatment schedules, which is key to designing effective antibiotic therapies.

Citing Articles

In vitro and in vivo activities of scutellarein, a novel polyphosphate kinase 1 inhibitor against Acinetobacter baumannii infection.

Song Y, Lv H, Xu L, Liu Z, Wang J, Fang T Microb Cell Fact. 2024; 23(1):269.

PMID: 39379932 PMC: 11462863. DOI: 10.1186/s12934-024-02540-9.


Bacterial Persister Cells and Development of Antibiotic Resistance in Chronic Infections: An Update.

Kunnath A, Suodha Suoodh M, Chellappan D, Chellian J, Palaniveloo K Br J Biomed Sci. 2024; 81:12958.

PMID: 39170669 PMC: 11335562. DOI: 10.3389/bjbs.2024.12958.

References
1.
Windels E, Michiels J, Fauvart M, Wenseleers T, Van den Bergh B, Michiels J . Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates. ISME J. 2019; 13(5):1239-1251. PMC: 6474225. DOI: 10.1038/s41396-019-0344-9. View

2.
Bakkeren E, Huisman J, Fattinger S, Hausmann A, Furter M, Egli A . Salmonella persisters promote the spread of antibiotic resistance plasmids in the gut. Nature. 2019; 573(7773):276-280. PMC: 6744281. DOI: 10.1038/s41586-019-1521-8. View

3.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

4.
Khare A, Tavazoie S . Extreme Antibiotic Persistence via Heterogeneity-Generating Mutations Targeting Translation. mSystems. 2020; 5(1). PMC: 6977076. DOI: 10.1128/mSystems.00847-19. View

5.
Windels E, Van den Bergh B, Michiels J . Bacteria under antibiotic attack: Different strategies for evolutionary adaptation. PLoS Pathog. 2020; 16(5):e1008431. PMC: 7205213. DOI: 10.1371/journal.ppat.1008431. View